Table 2.
Comparison between patients with and without infectious complications (n = 2014)
| Variable | Infectious complications | p value | |
|---|---|---|---|
| No (n = 1409) | Yes (n = 605) | ||
| Age, median (IQR), year | 75 (63–82) | 74 (64–83) | 0.457 |
| Sex, male, n (%) | 768 (54.5) | 320 (52.9) | 0.505 |
| History of hypertension, n (%) | 1089 (77.3) | 490 (81.0) | 0.143 |
| History of diabetes, n (%) | 300 (21.3) | 136 (22.5) | 0.813 |
| History of hypercholesterolemia, n (%) | 541 (38.4) | 226 (37.4) | 0.854 |
| Antiplatelet treatment, n (%) | 670 (47.6) | 286 (47.3) | 0.833 |
| Warfarin treatment, n (%) | 302 (21.4) | 121 (20.0) | 0.594 |
| Pre-stroke dependence, n (%) | 168/1279 (13.9) | 103/554 (18.6) | 0.003 |
| Baseline ICH volume, median (IQR), mL | 17 (5–60) | 16 (5–40) | 0.137 |
| Admission GCS, median (IQR) | 14 (7–15) | 13 (8–15) | 0.427 |
| Infratentorial location, n (%) | 173 (12.3) | 61 (10.1) | 0.189 |
| IVH presence, n (%) | 676 (48.0) | 321 (53.1) | 0.094 |
| Intubation, n (%) | 485 (34.4) | 224 (37.0) | 0.388 |
| Surgery, n (%) | 81 (5.7) | 50 (8.3) | 0.097 |
| Leukopenia, n (%) | 13 (0.9) | 7 (1.2) | 0.627 |
| Neutropenia, n (%) | 1 (0.1) | 2 (0.3) | 0.167 |
| Monocytopenia, n (%) | 62 (4.4) | 25 (4.1) | 0.786 |
| Lymphopenia, n (%) | 357 (25.3) | 191 (31.6) | 0.004 |
| Length of hospital stay, median (IQR), days | 5 (2–8) | 11 (6–19) | <0.001 |
| 90-day mortality, n (%) | 560 (39.7) | 183 (30.2) | <0.001 |
IQR interquartile range, ICH intracerebral hemorrhage, GCS Glasgow Coma Scale, IVH intraventricular hemorrhage